Saturday, 10 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

09:11 IST NSE
New Order WinMagellanic Cloud Ltd MCLOUD

Magellanic Cloud Bags ₹11.5 Cr Order

Magellanic Cloud Ltd's subsidiary, Motivity Labs Inc., secured a purchase order from Google LLC valued at approximately USD 1.21 million to provide technical solutions.

Value
₹11.50 Cr
08:31 IST NSE
Regulatory ApprovalBiocon Ltd BIOCON

Biocon Regulatory Approval

Biocon received Health Canada approval for its Yesintek (ustekinumab) Autoinjector Pen. This new product format expands the company's immunology portfolio in Canada.

07:52 IST NSE
Business UpdateValor Estate Ltd DBREALTY

Valor Estate Business Update

Valor Estate incorporated a subsidiary and executed a Concession Agreement for a Goa development project. The project involves an International Convention Centre and Convention Hotel.

07:34 IST NSE
New Order WinInox Wind Ltd INOXWIND

Inox Wind Bags ₹1,600 Cr Order

Inox Wind secured a 200 MW turnkey order from NLC India Limited, valued at approximately ₹1,600 crore, to be executed within 24 months.

Value
₹1,600 Cr
Execution
24 months
23:40 IST BSE
Fund RaiseDiamond Power Infrastructure Ltd DIACABS

Diamond Power Infrastructure Fund Raise of ₹1,614 Cr

Diamond Power Infrastructure raised funds via a QIP of 7,11,00,000 equity shares at ₹227 per share. The issue is now closed.

Value
₹1,614 Cr
23:20 IST NSE
Merger & Restructuring5Paisa Capital Ltd 5PAISA

5Paisa Capital Merger & Restructuring Worth ₹121.6 Cr

5paisa Capital Limited will acquire 100% of Giskard Datatech Private Limited for Rs. 121.57 Crore. The acquisition aims to integrate advanced data analytics into its digital platform.

Value
₹121.6 Cr
Execution
Upto 6 months
22:39 IST BSE
Product LaunchGlenmark Pharmaceuticals Ltd GLENMARK

Glenmark Pharmaceuticals Product Launch

Glenmark Pharmaceuticals launched Sugammadex Injection in the U.S. market. This addition strengthens the company's injectable portfolio and presence in the hospital segment.